Phase II Study to Evaluate the Efficacy and Safety of...

  • Main
  • 2018 / 04
  • Phase II Study to Evaluate the Efficacy and Safety of...
The Oncologist 2018 / 04

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma

Affronti, Mary Lou, Jackman, Jennifer Gamboa, McSherry, Frances, Herndon, James E., Massey, Elwood C., Lipp, Eric, Desjardins, Annick, Friedman, Henry S., Vlahovic, Gordana, Vredenburgh, James, Peters
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0149
Date:
April, 2018
File:
PDF, 261 KB
english, 2018
Conversion to is in progress
Conversion to is failed